FINE trial
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The FINE trial[1] was a study examining treatments for ME/CFS. It is considered to be the 'sister' to the PACE trial.
Funding[edit | edit source]
Results[edit | edit source]
Sam Carter applied the criteria from a PACE trial study to the data from the FINE trial and questioned whether the recovery rates in the PACE study had been inflated by as much as six-fold as a result.[2]
Criticism[edit | edit source]
- 2015, Trial By Error, Continued: Why has the PACE Study’s “Sister Trial” been “Disappeared” and Forgotten?
- 2010, Not So Fine After All: the FINE Trial Crashes to Earth
- FINE Trials Experience
- Failure of FINE trial comes as no surprise’ – MEA responds to study results in British Medical Journal
- Add to FINE page https://forbetterscience.wordpress.com/2016/05/20/plos-correction-removes-previously-available-anonymised-patient-clinical-trial-data/
Consent Form[edit | edit source]
- Add FINE consent form http://retractionwatch.com/wp-content/uploads/2016/05/11.4.16-Mitchell-Response-consent-form-version3-MREC-2460904.pdf
Investigators[edit | edit source]
Alison Wearden, Riste L, Dowrick C, Chew-Graham C, Bentall RP, Richard Morriss, Peters S, Dunn G, Richardson G, Lovell K, Powell P.